Answer:
Ximena's mom returned with the lab report of her blood lipid profile. Her HDL cholesterol was low and her LDL cholesterol levels were high. The doctor asked her to look closely at her diet. He asked her to increase unsaturated fats and to decrease saturated fats in her diet
Explanation:
Lipids are the most diverse range of compounds that are nonpolar in nature. The lipids are components of the cell membranes. They are formed of fatty acids, glycerol and a phosphate group. In the fatty acids of the unsaturated fats, there are the presence of double bonds. However, in case of the saturated fats, the double bonds are absent. Such fats are saturated with hydrogens atoms. A type of lipid that play important roles in the body is cholesterol.
There are two types of lipoprotein that carry cholesterol in blood. The HDL or high density lipoprotein is termed as good cholesterol, as it carries the cholesterol back to the liver to eliminate it from the body. LDL or low density lipoprotein is the bad cholesterol, as it carries cholesterol and accumulates it in the arteries to form plaques. A lipid profile is a routine blood test that assess the levels of HDL and LDL in blood. Increase in unsaturated fat causes rise in HDL, that is good for cardiovascular health.
Learn more about cholesterol levels here:
brainly.com/question/12905818
#SPJ4
Answer:
a. Cats see low-frequency, low contrast objects better than humans.
Explanation:
Mr. Big is able to see something that Pamela does not see because cats have a wider field view of about 200 degrees while that of humans is about 180 degrees.
Cats eyes have 6-8 times more rod cells, which are more sensitive to low light, than that of humans. Their elliptical eye shape, large tapetum and cornea help to gather light for better vision at night.
Answer:
solve the followig problem and write in your answer sheet of paper
Explanation:
solve the followig problem and write in your answer sheet of paper
Answer:
A
Explanation:
Everywhere is a danger zone. Set limits ang a proper and calm communication can at least reduce violent act
A Drug Trend report published in 2009 had predicted continued price increase among traditional branded and biotech drugs that lack generic competition. Now, further, CMS has reduced its Average Sales price (ASP) margin from 6 percent to 4 percent for non-pass-thorough. This has affected pharmacy reimbursement. However, there are certain other aspects of Pharmacy Billing that can affect reimbursement and thereby the Revenue Cycle Management (RCM) process if not well implemented.
1. Data Workflow:
Recognizing how the revenue cycle works in pharmacy is very essential. Procurement to Inventory, billing and reimbursement involves purchase of medications, their storage, and method of dispensing, how they are administered, way they are coded & billed, and finally reimbursed. If the drug is covered as a pharmacy benefit, or the payer needs that to be obtained via a specialty pharmacy as identified through patient-specific benefit verification, then here both the provider and the pharmacy are part of the reimbursement process. The physician writes a prescription and orders the drug. This is followed by the pharmacy that fills the order and issues the drug to the physician, CMHC, or hospital outpatient department. Here the pharmacy bills the insurance company for the drug. If any information is entered incorrectly into the pharmacy system in the initial phase of the cycle, errors can prove to be costly, impacting aspects of clinical and revenue cycle.
2. Procurement:
During this phase information is converted from purchased quantities and pricing to storage units of measure (UOM) and inventory costs. Manually entering the data is followed in most cases. UOM conversions, when data is uploaded from the wholesale distributor to the pharmacy system, are also checked and verified manually. Here too mistakes can lead to breakdown in the revenue cycle management (RCM) process.
3. The Charge master:
Critical & substantial revenue leakage can occur when separately reimbursable medications are either missing from or miscoded in the charge master. Conversion of pharmaceutical quantities is a must from purchased amounts to patient-administered amounts, and only then made billable. There is often a difference between dosage amounts required for patient use as from that purchased. Besides inventory, the clinician and pharmacist should convert dosage, strength, and delivery mechanism for each drug. Drug data must be correctly converted from the quantities residing in clinical systems into the payer-billable quantities appropriate for the financial system or charge master. The UOMs must be reconciled to avoid any under- or over-payments. More than often, missing or incorrect data in the charge master can result in negative financial consequences – denied claims, partial reimbursement, and compliance risks.
4. Linkages between Purchases & Billing:
Most hospitals have separate processes to order drugs, administer them, and process reimbursement. Without linkage between pharmacy expenditures for medications (i.e., spend data) and the charge master, ensuring proper charge capture and optimal reimbursement is a challenge. Besides hospitals should have automated tools to identify charge capture errors precisely, so as to pinpoint when and where their occurrence to decreasing revenue loss.
